Endometrial cancer (EC) incidence has increased in recent decades. However, population-
based outcomes data are limited. In this retrospective cohort study, we examined …

Endometrial cancer (EC) is a prevalent gynecological malignancy, and metabolic disorders
are among its most significant risk factors. Abnormal iron metabolism is associated with the …

Objective To evaluate disease-free survival (DFS) and overall survival (OS) associated with
adjuvant carboplatin and paclitaxel chemotherapy interposed with radiation for advanced …

Objective Developing a non-invasive and reliable triage test for endometrial malignant
lesions is an important goal, as it could help to reduce the number of invasive diagnostic …

Atractylenolide II (AT-II), the major bioactive compound of Atractylodes macrocephala,
exhibits anti-cancer activity against many types of tumors, but the roles and the potential …

Background. Endometrial cancer is one of the three major gynecologic malignancies, and its
incidence continues to rise. ATPase family AAA structural domain-containing protein 2 …

Ovarian, cervical, and endometrial cancer are the three most common gynecological
malignancies that seriously threaten women's health. With the development of molecular …

Background: Numerous studies have shown a relationship between low serum selenium
levels and an increased risk of developing cancer. Methods: A total of 306 women …

This study aimed to assess the association between ABO blood type and incident of type I
endometrial cancer (EC), as well as the stage and differentiation. 213 patients with type I EC …

Endometrial cancer (EC) is the most common female genital tract malignant cancer.
Lymphatic staging is a major prognostic factor and the main predictor of recurrence. The aim …